UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000006100
Receipt number R000007217
Scientific Title Examination of a new medicine notebook format for patient information sharing
Date of disclosure of the study information 2011/08/02
Last modified on 2015/08/25 11:33:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Examination of a new medicine notebook format for patient information sharing

Acronym

Examination of a new format for patient information sharing

Scientific Title

Examination of a new medicine notebook format for patient information sharing

Scientific Title:Acronym

Examination of a new format for patient information sharing

Region

Japan


Condition

Condition

All diseases

Classification by specialty

Medicine in general Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In this study, we extract problems and the improvement in the healthcare setting for the purpose of the smooth information sharing between the hospital, community pharmacy, the patient and make the final format.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

We interview it before and after the use of the format analyze the interview date.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

Information sharing.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

* Patient who uses the hospital and community pharmacy of the study enforcement institution more than once a month.
* Patient who receives preparation of drugs in community pharmacy.
* Patient who it was got participation in this study.
* Patient who there is ability for agreement, and can follow an observance matter during a trial entry.

Key exclusion criteria

Under 20 years.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tomoka OSUMI

Organization

Chiba Pharmaceutical Association

Division name

Drug Information Center

Zip code


Address

9-2 Tonyacho, Chuo-ku, Chiba-shi, Chiba

TEL

043-247-4401

Email

drug-info@c-yaku.or.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tomoka OSUMI

Organization

Chiba Pharmaceutical Association

Division name

Drug Information Center

Zip code


Address

9-2 Tonyacho, Chuo-ku, Chiba-shi, Chiba

TEL

043-247-4401

Homepage URL


Email

drug-info@c-yaku.or.jp


Sponsor or person

Institute

Tomoka OSUMI

Institute

Department

Personal name



Funding Source

Organization

Chiba Pharmaceutical Association

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2011 Year 08 Month 02 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

In our study, work physician one person after use of the cooperation format, pharmacy pharmacist three people, was carried out interviews in 6 patients.
It analyzes the interview contents were improved to a more appropriate format.
Physicians, pharmacists and patients to take advantage of this format, we had to share a treatment and drug information.
Further, as a problem of the format used in the study, was also obtained as a result of the amount of information as described in the paper is limited.
This research results in the medical workers - as an information sharing tool between patients, was verified and correct cooperation format. However, since the sample size is small, there is a possibility that the deviation occurs. The cooperation format that was created from the present study the future that plays what role in the region, there is a need to follow-up.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 06 Month 14 Day

Date of IRB


Anticipated trial start date

2011 Year 07 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2011 Year 08 Month 02 Day

Last modified on

2015 Year 08 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007217


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name